| 產(chǎn)品編號(hào) | bs-19775R-BF350 |
| 英文名稱(chēng)1 | Rabbit Anti-RBM6/BF350 Conjugated antibody |
| 中文名稱(chēng) | BF350標(biāo)記的RNA結(jié)合蛋白6抗體 |
| 別 名 | 3G2; 4930506F14Rik; DEF 3; DEF3; DKFZp686B0877; FLJ36517; g16; HLC 11; KIAA4015; Lung cancer antigen NY LU 12; Lung cancer antigen NY-LU-12; Lung cancer protooncogene 11; mKIAA4015; NY LU 12; Protein G16; RBM6; RBM6/RBM5 fusion; RBM6_HUMAN; RGD1560367; RNA binding motif protein 6; RNA-binding motif protein 6; RNA-binding protein 6; RNA-binding protein DEF-3. |
| 規(guī)格價(jià)格 | 100ul/2980元 購(gòu)買(mǎi) 大包裝/詢(xún)價(jià) |
| 說(shuō) 明 書(shū) | 100ul |
| 研究領(lǐng)域 | 細(xì)胞生物 結(jié)合蛋白 表觀遺傳學(xué) |
| 抗體來(lái)源 | Rabbit |
| 克隆類(lèi)型 | Polyclonal |
| 交叉反應(yīng) | Human, (predicted: Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep, ) |
| 產(chǎn)品應(yīng)用 | ICC=1:50-200 IF=1:50-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 129kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human RBM6 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲(chǔ) 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol |
| 保存條件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 產(chǎn)品介紹 |
Function: Specifically binds poly(G) RNA homopolymers in vitro. Subcellular Location: Nucleus. Tissue Specificity: Ubiquitous in adults. Similarity: Contains 1 G-patch domain. Contains 1 RRM (RNA recognition motif) domain. Database links: Entrez Gene: 10180 Human Entrez Gene: 19654 Mouse Omim: 606886 Human SwissProt: P78332 Human Unigene: 696735 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
